Bladder cancer treatment doubles survival

Patients living with bladder cancer can receive a treatment that can double survival rates from the disease. The treatment which has been approved for use on the NHS has been hailed as one of the most hopeful advances in decades for people with bladder cancer. Around 1,250 patients with bladder cancer in England a year could be offered the therapy, which significantly boosts survival and remission rates. In clinical trials of the drug, people with bladder cancer that had spread (metastasised) lived up to twice as long when given the combination antibody treatment compared to those given normal chemotherapy.

Keep up to date

Sign up to receive our daily news alerts straight to your inbox. Subscribe to our weekly newsletter containing a summary of the week’s news, blog and vote on our poll.

Weekly Newsletter

Daily news updates

Have a discussion

Help keep the conversation going between meetings by creating a forum to hold discussions with your members. It’s an easy way to manage and communicate with members.

Create a network

Create a network to share documents, knowledge and best practice with your colleagues. Set up a network to keep in touch with other people in your organisation or with shared interest groups across organisational boundaries.

Networks can be open to all or available only to a closed group defined by the administrator.

Join or create a network here.